305 filings
8-K
PSTV
Plus Therapeutics Inc
14 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
PSTV
Plus Therapeutics Inc
13 Mar 24
Regulation FD Disclosure
8:01am
8-K
PSTV
Plus Therapeutics Inc
5 Mar 24
Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
4:04pm
8-K
PSTV
Plus Therapeutics Inc
20 Nov 23
Regulation FD Disclosure
7:01am
8-K
PSTV
Plus Therapeutics Inc
31 Oct 23
Other Events
4:55pm
8-K
3pyzgua8atf
31 Oct 23
Plus Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
4:06pm
8-K
f92wfbg
14 Aug 23
Plus Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
4:12pm
8-K
lkrt fjnx0rna
16 May 23
Other Events
8:09am
8-K
v4e48u
28 Apr 23
Plus Therapeutics Announces Reverse Stock Split
4:34pm
8-K
n2sysnzf
21 Apr 23
Submission of Matters to a Vote of Security Holders
6:30am
8-K
b38rhx64a
20 Apr 23
Plus Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
me19raz6s stuzdfobdv
13 Mar 23
Regulation FD Disclosure
6:30am
8-K
f2zt6 cnz1xy0
3 Mar 23
Entry into a Material Definitive Agreement
4:31pm
8-K
jsu08ba
23 Feb 23
Plus Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
4:10pm
8-K
riih7z kc
15 Dec 22
Other Events
4:28pm
8-K
4l1m3r
28 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
8-K
p2dxr 78c5owwzlf
20 Oct 22
Plus Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
4:33pm
8-K
m4kjgv9f2 47ymh2x
22 Sep 22
Plus Therapeutics Executes $17.6 Million Award Contract with Cancer
7:02am
8-K
3r1mj
9 Sep 22
Entry into a Material Definitive Agreement
4:43pm
8-K
e8jik
17 Aug 22
Other Events
5:27pm